CHK2-FOXK axis promotes transcriptional control of autophagy programs

Yuping Chen1,2, Jinhuan Wu1,2, Guang Liang3

  • 1Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, Shanghai 200120, China.

Science Advances
|January 9, 2020
PubMed

Insights

DNA damage triggers autophagy via the CHK2-FOXK pathway, enhancing cellular cleanup. A FOXK mutation causes chemoresistance, but combined treatment with cisplatin and chloroquine can overcome this resistance.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Autophagy is a crucial cellular process for maintaining homeostasis by clearing damaged components.
  • DNA damage response pathways are critical for cellular integrity and survival.
  • Transcriptional regulation plays a key role in modulating cellular processes like autophagy.

Purpose of the Study:

  • To elucidate the role of the CHK2-FOXK axis in DNA damage-induced autophagy.
  • To investigate the mechanism of transcriptional regulation in autophagy.
  • To understand the contribution of FOXK mutations to chemoresistance.

Main Methods:

  • Investigated the interaction between CHK2 and FOXK proteins following DNA damage.
  • Analyzed the effect of FOXK phosphorylation and cytoplasmic trapping on autophagy gene expression.
  • Utilized cancer cell models with wild-type and mutated FOXK to study chemoresistance.
  • Assessed the efficacy of cotreatment with cisplatin and chloroquine in overcoming chemoresistance.

Main Results:

  • Discovered that CHK2 phosphorylates FOXK upon DNA damage, leading to FOXK's cytoplasmic sequestration.
  • Demonstrated that cytoplasmic trapping of FOXK, a transcriptional repressor of autophagy genes (ATGs), induces autophagy.
  • Identified a cancer-derived FOXK mutation that enhances FOXK hyperphosphorylation, leading to increased autophagy and chemoresistance.
  • Showed that cotreatment with cisplatin and chloroquine effectively overcomes FOXK mutation-induced chemoresistance.

Conclusions:

  • The CHK2-FOXK pathway is a key regulator of DNA damage-induced autophagy at the transcriptional level.
  • Dysregulation of this pathway, particularly through FOXK mutations, contributes to cancer chemoresistance.
  • Targeting the CHK2-FOXK-autophagy axis offers potential therapeutic strategies for overcoming chemoresistance.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K